Genome Engineering Market to See Booming Growth 2021-2028 | Thermo Fisher Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc.

Overview:

Genome engineering, also known as genetic editing, gene manipulation, or genetic engineering, is basically a form of genetic engineering where DNA is introduced, inserted, deleted, or altered at the genetic level of an organism. It involves editing and modifying the genetic material of living organisms. Genome engineering technologies enable scientists to make changes in DNA, leading to changes in physical traits. In recent years, several approaches to genome editing have been developed.

Request Here For Market Latest Insights(PDF): https://www.coherentmarketinsights.com/insight/request-pdf/1262

Drivers:

Introduction of novel genome engineering technologies is expected to aid in the growth of the global genome engineering market. For instance, in December 2017, Synthego launched new CRISPRevolution Gene Knockout Kit (GKO) with the first guaranteed CRISPR gene editing solution. Moreover, in 2018, Synthego developed a new tool called ICE (short for Inference of CRISPR Edits) to make analyzing CRISPR experiments easier than ever.

Furthermore, key players active in the market are adopting various inorganic strategies, such as collaboration, to strengthen their product portfolio, which in turn is expected to boost the growth of the global genome engineering market. For instance, in 2018, Pfizer and Sangamo Therapeutics collaborated to develop a potential gene therapy for the treatment of amyotrophic lateral sclerosis (ALS).

Regional Analysis:

North America is expected to witness robust growth in the global genome engineering market due to the increasing research and development activities and presence of major key players in this region. For instance, in July 2017, Integrated DNA Technologies announced the launch of the first Cas9 enzyme variant that extensively reduces off-target effects in CRISPR genome editing without compromising on-target activity.

Purchase this Report - https://www.coherentmarketinsights.com/insight/buy-now/1262

Genome Engineering Market – Competitive Landscape

Key players functioning in the global prosthetic liners market consists of Thermo Fisher Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., Editas Medicine, Inc., Sangamo Therapeutics, Inc., Bluebird Bio, Inc., Cellectis S.A., and Merck Group.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Other Reports:

Endodontics Devices Market - https://www.coherentmarketinsights.com/press-release/endodontics-devices-market-3965

Multiplexed Diagnostic Market - https://www.coherentmarketinsights.com/press-release/multiplexed-diagnostic-market-to-surpass-us-155-billion-threshold-by-2025-buoyed-by-rising-prevalence-of-chronic-disorders-414

This release was published on openPR.